Skip to main content
Top
Published in: Child's Nervous System 8/2013

01-08-2013 | Case Report

Fatal hemorrhagic stroke in a Caucasian girl with moyamoya disease

Authors: Petra Schödel, Alexander Brawanski, Monika Friedrich, Felix Schlachetzki, Peter Heiss, Karl-Michael Schebesch

Published in: Child's Nervous System | Issue 8/2013

Login to get access

Abstract

Introduction

Moyamoya disease (MMD) is an extremely rare neurovascular disorder in Caucasian children. To the best of our knowledge, the aggressive variant including hemorrhagic malignant stroke and consecutive global ischemia has not been reported for this population before.

Case report

We present the case of an 11-year-old girl with sudden neurological deterioration due to intracerebral hemorrhage with early irruption into the ventricular system. MMD with extensive neovascularization was diagnosed by means of computed tomography and magnetic resonance imaging. Despite immediate ventricular drainage, intracranial pressure increased above the mean arterial pressure resulting in malignant bi-hemispheric ischemia. The girl died within 53 h after admission to hospital.

Discussion

Intracerebral hemorrhage in young patients is often attributed to vascular malformation. This case shows that MMD may constitute a potential diagnosis in the case of sudden neurological deterioration and loss of consciousness, even in previously healthy children.
Literature
1.
go back to reference Ahn JH, Wang KC, Phi JH, Lee JY, Cho BK, Kim IO, Kim SK (2012) Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Childs Nerv Syst 28:237–245PubMedCrossRef Ahn JH, Wang KC, Phi JH, Lee JY, Cho BK, Kim IO, Kim SK (2012) Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Childs Nerv Syst 28:237–245PubMedCrossRef
2.
go back to reference Ayer RE, Zhang JH (2008) The clinical significance of acute brain injury in subarachnoid hemorrhage and opportunity for intervention. Acta Neurochir Suppl 105:179–184PubMedCrossRef Ayer RE, Zhang JH (2008) The clinical significance of acute brain injury in subarachnoid hemorrhage and opportunity for intervention. Acta Neurochir Suppl 105:179–184PubMedCrossRef
3.
go back to reference Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307PubMedCrossRef Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307PubMedCrossRef
4.
go back to reference Chiu D, Shedden P, Bratina P, Grotta JC (1998) Clinical features of moyamoya disease in the United States. Stroke 29:1347–1351PubMedCrossRef Chiu D, Shedden P, Bratina P, Grotta JC (1998) Clinical features of moyamoya disease in the United States. Stroke 29:1347–1351PubMedCrossRef
5.
go back to reference Dusick JR, Gonzalez NR, Martin NA (2011) Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68:34–43, discussion 43PubMedCrossRef Dusick JR, Gonzalez NR, Martin NA (2011) Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 68:34–43, discussion 43PubMedCrossRef
6.
go back to reference Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, Mikulis DJ, Tymianski M (2011) Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42:3047–3054PubMedCrossRef Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, Mikulis DJ, Tymianski M (2011) Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42:3047–3054PubMedCrossRef
7.
go back to reference Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M (1997) Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99(Suppl 2):S6–S10PubMedCrossRef Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M (1997) Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99(Suppl 2):S6–S10PubMedCrossRef
8.
go back to reference Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81:673–678PubMedCrossRef Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81:673–678PubMedCrossRef
9.
go back to reference Kim DS, Jang DK, Huh PW, Yoo DS, Han YM, Huh CW (2011) Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease: six new cases and a short literature review. Acta Neurochir (Wien) 153:1253–1261CrossRef Kim DS, Jang DK, Huh PW, Yoo DS, Han YM, Huh CW (2011) Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease: six new cases and a short literature review. Acta Neurochir (Wien) 153:1253–1261CrossRef
10.
go back to reference Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101PubMedCrossRef Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC (2010) Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol 68:92–101PubMedCrossRef
11.
go back to reference King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, Alleyne CH, Dhandapani KM (2010) Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 28:E10PubMedCrossRef King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, Alleyne CH, Dhandapani KM (2010) Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus 28:E10PubMedCrossRef
12.
go back to reference Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47PubMedCrossRef Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T (2008) Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42–47PubMedCrossRef
13.
go back to reference Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J (2012) Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 84(3):258–265PubMedCrossRef Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J (2012) Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 84(3):258–265PubMedCrossRef
14.
go back to reference Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965–976PubMedCrossRef Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965–976PubMedCrossRef
15.
go back to reference Nishimoto A, Takeuchi S (1968) Abnormal cerebrovascular network related to the internal cartoid arteries. J Neurosurg 29:255–260PubMedCrossRef Nishimoto A, Takeuchi S (1968) Abnormal cerebrovascular network related to the internal cartoid arteries. J Neurosurg 29:255–260PubMedCrossRef
16.
go back to reference Oshima H, Katayama Y (2012) Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s. Childs Nerv Syst 28:497–500PubMedCrossRef Oshima H, Katayama Y (2012) Discovery of cerebrovascular moyamoya disease: research during the late 1950s and early 1960s. Childs Nerv Syst 28:497–500PubMedCrossRef
17.
go back to reference Pandey P, Steinberg GK (2011) Neurosurgical advances in the treatment of moyamoya disease. Stroke 42:3304–3310PubMedCrossRef Pandey P, Steinberg GK (2011) Neurosurgical advances in the treatment of moyamoya disease. Stroke 42:3304–3310PubMedCrossRef
18.
go back to reference Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim WC, Kim OJ, Kim TG, Choi JU, Kim DS, Kim NK (2012) The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7:e47158PubMedCrossRef Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim WC, Kim OJ, Kim TG, Choi JU, Kim DS, Kim NK (2012) The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 7:e47158PubMedCrossRef
19.
go back to reference Rafay MF, Smith SE, Dirks P, Armstrong D, deVeber GA (2006) Hemorrhage predisposing to cerebral infarction in children with moyamoya disease. Pediatr Neurol 34:400–404PubMedCrossRef Rafay MF, Smith SE, Dirks P, Armstrong D, deVeber GA (2006) Hemorrhage predisposing to cerebral infarction in children with moyamoya disease. Pediatr Neurol 34:400–404PubMedCrossRef
20.
go back to reference Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J (2008) MMP-9-positive neutrophil infiltration is associated to blood–brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39:1121–1126PubMedCrossRef Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J (2008) MMP-9-positive neutrophil infiltration is associated to blood–brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39:1121–1126PubMedCrossRef
22.
go back to reference Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRef Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288–299PubMedCrossRef
23.
go back to reference Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR (2011) Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 30:E20PubMedCrossRef Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR (2011) Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 30:E20PubMedCrossRef
24.
go back to reference Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y (1999) Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-Up study. Stroke 30:2272–2276PubMedCrossRef Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y (1999) Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-Up study. Stroke 30:2272–2276PubMedCrossRef
Metadata
Title
Fatal hemorrhagic stroke in a Caucasian girl with moyamoya disease
Authors
Petra Schödel
Alexander Brawanski
Monika Friedrich
Felix Schlachetzki
Peter Heiss
Karl-Michael Schebesch
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 8/2013
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-013-2089-5

Other articles of this Issue 8/2013

Child's Nervous System 8/2013 Go to the issue